{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T15:49:16Z","timestamp":1771256956256,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82300089"],"award-info":[{"award-number":["82300089"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-025-03524-0","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T15:01:24Z","timestamp":1742050884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk prediction and early intervention strategies for persistent SARS-CoV-2 infection in patients with non-Hodgkin lymphoma: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Wailong","family":"Zou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuwei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaxin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jichao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,15]]},"reference":[{"key":"3524_CR1","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059\u201368.","journal-title":"J Clin Oncol"},{"key":"3524_CR2","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/S0140-6736(20)31187-9","volume":"395","author":"NM Kuderer","year":"2020","unstructured":"Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395:1907\u201318.","journal-title":"Lancet"},{"key":"3524_CR3","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1038\/s41375-020-0836-7","volume":"34","author":"W He","year":"2020","unstructured":"He W, Chen L, Chen L, Yuan G, Fang Y, Chen W, et al. COVID-19 in persons with haematological cancers. Leukemia. 2020;34:1637\u201345.","journal-title":"Leukemia"},{"key":"3524_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/v16030328","volume":"16","author":"M Saito","year":"2024","unstructured":"Saito M, Mori A, Ishio T, Kobayashi M, Tsukamoto S, Kajikawa S, et al. Initial efficacy of the COVID-19 mRNA vaccine booster and subsequent breakthrough omicron variant infection in patients with B-cell non-hodgkin\u2019s lymphoma: a single-center cohort study. Viruses. 2024;16:328.","journal-title":"Viruses"},{"key":"3524_CR5","doi-asserted-by":"publisher","first-page":"eabd0110","DOI":"10.1126\/sciimmunol.abd0110","volume":"5","author":"M Roschewski","year":"2020","unstructured":"Roschewski M, Lionakis MS, Sharman JP, Roswarski J, Goy A, Monticelli MA, et al. Inhibition of Bruton tyrosine kinase in patients with severe COVID-19. Sci Immunol. 2020;5:eabd0110.","journal-title":"Sci Immunol"},{"key":"3524_CR6","doi-asserted-by":"publisher","first-page":"101541","DOI":"10.1016\/j.tranon.2022.101541","volume":"26","author":"S Bravaccini","year":"2022","unstructured":"Bravaccini S, Nicolini F, Zanoni M, Gaimari A, Cerchione C, Maltoni R, et al. Why the complications of COVID-19 patients differ in elderly and young cancer patients. Transl Oncol. 2022;26:101541.","journal-title":"Transl Oncol"},{"key":"3524_CR7","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1002\/jmv.25972","volume":"92","author":"F Yang","year":"2020","unstructured":"Yang F, Shi S, Zhu J, Shi J, Dai K, Chen X. Clinical characteristics and outcomes of cancer patients with COVID-19. J Med Virol. 2020;92:2067\u201373.","journal-title":"J Med Virol"},{"key":"3524_CR8","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1097\/RLU.0000000000004973","volume":"49","author":"R Teixeira Ferreira","year":"2024","unstructured":"Teixeira Ferreira R, Cardoso Ferreira I, Carmona S, Montalv\u00e3o A, Santos AI. Spontaneous remission of high-grade non-hodgkin lymphoma after SARS-CoV-2 infection: a case report. Clin Nucl Med. 2024;49:e77\u20139.","journal-title":"Clin Nucl Med"},{"key":"3524_CR9","doi-asserted-by":"publisher","first-page":"e453","DOI":"10.1016\/S1473-3099(23)00815-0","volume":"24","author":"HM Machkovech","year":"2024","unstructured":"Machkovech HM, Hahn AM, Garonzik Wang J, Grubaugh ND, Halfmann PJ, Johnson MC, et al. Persistent SARS-CoV-2 infection: significance and implications. Lancet Infect Dis. 2024;24:e453\u201362.","journal-title":"Lancet Infect Dis"},{"key":"3524_CR10","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.cell.2020.10.049","volume":"183","author":"VA Avanzato","year":"2020","unstructured":"Avanzato VA, Matson MJ, Seifert SN, Pryce R, Williamson BN, Anzick SL, et al. Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer. Cell. 2020;183:1901\u201312..e9.","journal-title":"Cell"},{"key":"3524_CR11","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1056\/NEJMc2031670","volume":"383","author":"T Aydillo","year":"2020","unstructured":"Aydillo T, Gonzalez-Reiche AS, Aslam S, van de Guchte A, Khan Z, Obla A, et al. Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer. N Engl J Med. 2020;383:2586\u20138.","journal-title":"N Engl J Med"},{"key":"3524_CR12","doi-asserted-by":"publisher","first-page":"911339","DOI":"10.3389\/fimmu.2022.911339","volume":"13","author":"A D\u2019Abramo","year":"2022","unstructured":"D\u2019Abramo A, Vita S, Maffongelli G, Beccacece A, Agrati C, Cimini E, et al. Clinical management of patients with B-cell depletion agents to treat or prevent prolonged and severe SARS-COV-2 infection: defining a treatment pathway. Front Immunol. 2022;13:911339.","journal-title":"Front Immunol"},{"key":"3524_CR13","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s11739-021-02705-z","volume":"16","author":"S Corcione","year":"2021","unstructured":"Corcione S, Lupia T, Raviolo S, Montrucchio G, Trentalange A, Curtoni A, et al. Putative invasive pulmonary aspergillosis within medical wards and intensive care units: a 4-year retrospective, observational, single-centre study. Intern Emerg Med. 2021;16:1619\u201327.","journal-title":"Intern Emerg Med"},{"key":"3524_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.4103\/ijmr.IJMR_453_21","volume":"155","author":"AS Tripathy","year":"2022","unstructured":"Tripathy AS, Trimbake D, Suryawanshi PV, Tripathy SP, Gurav YK, Potdar VA, et al. Peripheral lymphocyte subset alteration in patients with COVID-19 having differential clinical manifestations. Indian J Med Res. 2022;155:136\u201347.","journal-title":"Indian J Med Res"},{"key":"3524_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.33549\/physiolres.934492","volume":"69","author":"J Paces","year":"2020","unstructured":"Paces J, Strizova Z, Smrz D, Cerny J. COVID-19 and the immune system. Physiol Res. 2020;69:379\u201388.","journal-title":"Physiol Res"},{"key":"3524_CR16","doi-asserted-by":"publisher","first-page":"e84790","DOI":"10.7554\/eLife.84790","volume":"12","author":"NS Brunetti","year":"2023","unstructured":"Brunetti NS, Davanzo GG, de Moraes D, Ferrari AJR, Souza GF, Muraro SP, et al. SARS-CoV-2 uses CD4 to infect T helper lymphocytes. eLife. 2023;12:e84790.","journal-title":"eLife"},{"key":"3524_CR17","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3390\/v15020400","volume":"15","author":"A Vojdani","year":"2023","unstructured":"Vojdani A, Vojdani E, Saidara E, Maes M, Persistent. SARS-CoV-2 infection, EBV, HHV-6 and other factors may contribute to inflammation and autoimmunity in long COVID. Viruses. 2023;15:400.","journal-title":"Viruses"},{"key":"3524_CR18","doi-asserted-by":"publisher","first-page":"e2111417","DOI":"10.1001\/jamanetworkopen.2021.11417","volume":"4","author":"T Nasserie","year":"2021","unstructured":"Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4:e2111417.","journal-title":"JAMA Netw Open"},{"key":"3524_CR19","doi-asserted-by":"publisher","first-page":"6304189","DOI":"10.1155\/2021\/6304189","volume":"2021","author":"Y Li","year":"2021","unstructured":"Li Y, Li H, Song C, Lu R, Zhao Y, Lin F, et al. Early prediction of disease progression in patients with severe COVID-19 using C-reactive protein to albumin ratio. Dis Markers. 2021;2021:6304189.","journal-title":"Dis Markers"},{"key":"3524_CR20","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.cell.2020.10.001","volume":"183","author":"BJ Meckiff","year":"2020","unstructured":"Meckiff BJ, Ram\u00edrez-Su\u00e1stegui C, Fajardo V, Chee SJ, Kusnadi A, Simon H, et al. Imbalance of regulatory and cytotoxic SARS-CoV-2-Reactive CD4+ T cells in COVID-19. Cell. 2020;183:1340\u2013e135316.","journal-title":"Cell"},{"key":"3524_CR21","doi-asserted-by":"publisher","first-page":"n1648","DOI":"10.1136\/bmj.n1648","volume":"374","author":"H Crook","year":"2021","unstructured":"Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648.","journal-title":"BMJ"},{"key":"3524_CR22","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8:e21.","journal-title":"Lancet Respir Med"},{"key":"3524_CR23","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/S0140-6736(20)31173-9","volume":"395","author":"LYW Lee","year":"2020","unstructured":"Lee LYW, Cazier JB, Angelis V, Arnold R, Bisht V, Campton NA, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395:1919\u201326.","journal-title":"Lancet"},{"key":"3524_CR24","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","volume":"11","author":"B Diao","year":"2020","unstructured":"Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol. 2020;11:827.","journal-title":"Front Immunol"},{"key":"3524_CR25","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1007\/s00134-020-06211-2","volume":"46","author":"J Xie","year":"2020","unstructured":"Xie J, Wu W, Li S, Hu Y, Hu M, Li J, et al. Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study. Intensive Care Med. 2020;46:1863\u201372.","journal-title":"Intensive Care Med"},{"key":"3524_CR26","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","volume":"5","author":"T Guo","year":"2020","unstructured":"Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:811\u20138.","journal-title":"JAMA Cardiol"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03524-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03524-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03524-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T15:01:26Z","timestamp":1742050886000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03524-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,15]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3524"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03524-0","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,15]]},"assertion":[{"value":"24 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Board of the Aerospace Center Hospital (no. 2022-075) and was conducted according to the tenets of the Declaration of Helsinki. The need for informed consent was waived because of the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"122"}}